| Metric | Value ($ M) | Q2 FY25 | Q3 FY24 |
|---|---|---|---|
| Revenue | 5.1K | 0.1% | 20.3% |
| Total Income | 5.1K | 0.1% | 20.3% |
| Expenditure | 4.0K | 5.3% | 15.6% |
| PBT | 939.00 | 0.2% | 40.4% |
| Net Profit | 755.00 | 5.3% | 61.0% |
| OPM | 20.69% | 4.51pp | 3.28pp |
| NPM | 14.91% | 0.84pp | 3.76pp |
| EPS | 0.51 | 5.6% | 59.4% |
Boston Scientific Reports Q3 2025 Results
04 May 2026 · 4 May, 8:54 am
Summary
The press release announces Boston Scientific Corporation's financial results for the third quarter ended September 30, 2025.
Informational and educational content only. Not investment advice.